NASDAQ / LIVE COMPANY INTELLIGENCE

Integra LifeSciences Holdings Corporation

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERIART
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / IART COVERAGE

What’s moving Integra LifeSciences Holdings Corporation now

Current reporting with the operating signal separated from the noise.

01
Integra LifeSciences Holdings Corporation: Integra LifeSciences Reports Second Quarter 2026 Financial Results

Integra LifeSciences Holdings Corporation: Integra LifeSciences Reports Second Quarter 2026 Financial Results

The story matters when it changes Integra LifeSciences Holdings Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Integra LifeSciences Holdings Corporation: Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

Integra LifeSciences Holdings Corporation: Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

The decision can change Integra LifeSciences Holdings Corporation’s market access, costs and competitive freedom.

Watch next: regulator filings, verified operating scope and liability disclosures.
03
Integra LifeSciences Holdings Corporation (IART) Q3 2025 Earnings Call Transcript

Integra LifeSciences Holdings Corporation (IART) Q3 2025 Earnings Call Transcript

Investors are testing whether Integra LifeSciences Holdings Corporation’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
Integra LifeSciences Holdings Corporation (IART) Focuses on Supply Chain Recovery and Growth Strategy

Integra LifeSciences Holdings Corporation (IART) Focuses on Supply Chain Recovery and Growth Strategy

The development tests whether Integra LifeSciences Holdings Corporation can turn product investment into adoption, revenue and durable advantage.

Watch next: confirmation in a company filing, official release or regulator record.
05
Here’s Why Integra LifeSciences Holdings Corporation (IART) Fell in Q3

Here’s Why Integra LifeSciences Holdings Corporation (IART) Fell in Q3

The story matters when it changes Integra LifeSciences Holdings Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
06
Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation

The story matters when it changes Integra LifeSciences Holdings Corporation’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest IART filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-07-29 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-05-05 · Period 2026-03-31SEC ↗10-KAnnual financial reportFiled 2026-02-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-29 · Period 2026-07-29SEC ↗8-KMaterial company eventFiled 2026-05-08 · Period 2026-05-07SEC ↗8-KMaterial company eventFiled 2026-05-05 · Period 2026-04-30SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-06 · Period 2025-12-31SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-07-31SEC ↗
EARNINGS / QUARTERLY TRACKER

Integra LifeSciences Holdings Corporation, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.